Dexmetedomedine is one of 27 small molecule programs targeting Surgery. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
33 competitors in Surgery
Alfenta
Journavx
Neo-Synephrine
Nubain
Levophed
Desferal
Cardene
Tukysa
Senna
Inlyta
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details